• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: APOLLO ENDOSURGERY OVERSTITCH ENDOSCOPIC SUTURING SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

APOLLO ENDOSURGERY OVERSTITCH ENDOSCOPIC SUTURING SYSTEM Back to Search Results
Model Number ESS-G02-160
Device Problem Patient-Device Incompatibility (2682)
Patient Problem Abscess (1690)
Event Date 12/10/2020
Event Type  Injury  
Manufacturer Narrative
Initial medwatch submitted to the fda on 10/mar/2021.A review of the device labeling notes the following: the current overstitch¿ endoscopic suturing system (ess) instructions for use (ifu) addressed the known and potential event of "other-clinical outcome device related" as follows: warnings: only physicians possessing sufficient skill and experience in similar or the same techniques should perform endoscopic procedures.Users should be familiar with surgical procedures and techniques involving absorbable sutures before employing synthetic absorbable sutures for wound closure, as the risk of wound dehiscence may vary with the site of application and the suture material used.Ensure that there is sufficient space for the needle to open.Warning: do not introduce the device with the needle body in its open position.Adverse event: possible complications that may result from using the endoscopic suturing system include, but may not be limited to: infection/sepsis, wound dehiscence.
 
Event Description
Patient presented with an internal abscess.Patient was hospitalized and treated successfully.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OVERSTITCH ENDOSCOPIC SUTURING SYSTEM
Type of Device
SUTURING SYSTEM
Manufacturer (Section D)
APOLLO ENDOSURGERY
1120 s. capital of texas hwy
bldg 1, ste. 300
austin TX 78746
Manufacturer (Section G)
VIANT MEDICAL
5079 33rd street se
grand rapids MI 49512
Manufacturer Contact
david hooper
1120 s. capital of texas hwy
bldg 1, ste. 300
austin, TX 78746
MDR Report Key11454224
MDR Text Key238912534
Report Number3006722112-2021-00015
Device Sequence Number1
Product Code OCW
UDI-Device Identifier10811955020664
UDI-Public10811955020664
Combination Product (y/n)N
Reporter Country CodeIS
PMA/PMN Number
K081853
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Reporter Occupation Physician
Type of Report Initial
Report Date 12/10/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/10/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberESS-G02-160
Device Catalogue NumberESS-G02-160
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/10/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
-
-